Skip to main content
Medfolio
Blood Sugar · Glossary

Fasting Insulin

Fasting Serum Insulin

हिंदी · खाली पेट इंसुलिन

What the fasting insulin test measures, how it relates to insulin resistance and PCOS, why it is read alongside blood sugar, and when to see your doctor.

This page is general educational content. It describes what Fasting Insulin measures and how doctors generally interpret it. It does not interpret your individual result. Always discuss your reports with a qualified medical professional.

Reviewed by the Medfolio editorial team
Written for an Indian audience against current ICMR, WHO, and NIH guidance · Last updated 27 May 2026
In your home language — हिंदी · తెలుగు · தமிழ் · मराठी · ਪੰਜਾਬੀ translations coming

Also seen on reports as: Serum Insulin (Fasting), Insulin

What is Fasting Insulin?

Fasting Insulin measures the level of insulin circulating in the blood after the body has been without food for 8–12 hours. Insulin is the hormone the pancreas releases to help cells take up glucose from the blood; the fasting level shows the body's baseline insulin output.

Fasting insulin is usually most informative when interpreted alongside fasting glucose. The two together are used to calculate an insulin-resistance score called HOMA-IR (Homeostasis Model Assessment of Insulin Resistance), which estimates how hard the pancreas is having to work to keep fasting sugar in range.

The test is run on a small blood sample drawn from a vein. Reference ranges and units vary noticeably between Indian labs — most report in µIU/mL (microunits per millilitre), but some use pmol/L or mIU/L. Always interpret the value against the range printed on the same report.

Why doctors order it

Fasting insulin is most commonly ordered when a doctor suspects insulin resistance — for example, in someone with central (abdominal) obesity, polycystic ovary syndrome (PCOS), acanthosis nigricans (dark, velvety skin patches around the neck or armpits), fatty liver on ultrasound, or a strong family history of type-2 diabetes — even when fasting glucose is still in the normal range.

In Indian practice, where 'lean' type-2 diabetes and insulin resistance at normal body weight are relatively common, fasting insulin can pick up early signals that fasting glucose alone might miss. It is sometimes ordered as part of a metabolic-syndrome work-up alongside lipid profile, fasting glucose, HbA1c, and liver enzymes.

It is also used in PCOS management, in evaluating unexplained weight gain or treatment-resistant weight loss, and occasionally in suspected reactive hypoglycaemia. Fasting insulin is not used as a primary diabetes screening test — fasting glucose and HbA1c remain the front-line tests for that.

What the result means

There is no single universally agreed cut-off for what counts as 'high' or 'low' fasting insulin — different labs and different clinical groups use different thresholds. Most NABL-accredited Indian labs report a non-diabetic adult reference range that sits somewhere between 2.6 and 24.9 µIU/mL, though the exact endpoints differ.

Doctors often look at fasting insulin together with fasting glucose using HOMA-IR. A higher HOMA-IR value suggests the pancreas is having to release more insulin than usual to keep fasting sugar in range — a sign of insulin resistance. HOMA-IR cut-offs themselves are not uniform; some Indian groups use ≥2.5 as the working threshold for insulin resistance, others use ≥2.7 or higher.

A high fasting insulin in the presence of normal fasting glucose typically points to insulin resistance — the pancreas is still able to compensate, but is working harder. A low fasting insulin with high fasting glucose can point to a more advanced state where insulin production itself is reduced. Either pattern is read by the doctor in the context of the rest of the clinical picture.

Reference range

Values typically reported in µIU/mL. Exact reference range varies between Indian labs — always interpret against the range on the same report.

Typical adult reference range (non-diabetic)
Roughly 2.6 – 24.9 µIU/mL (lab-dependent)
HOMA-IR — insulin sensitivity (calculated, not measured)
Lower values suggest better sensitivity; higher values (often ≥2.5–2.7) suggest insulin resistance
Very low fasting insulin
Suggests reduced insulin production — interpret with fasting glucose

Fasting insulin reference ranges are NOT standardised across labs. Two readings from different labs cannot be directly compared. Doctors interpret the value alongside fasting glucose, HOMA-IR, and the clinical picture.

Common factors that affect the result

Like all fasting tests, the result is affected by fasting duration — typically 8–12 hours is required. Recent meals (especially carbohydrate-rich ones), recent intense exercise, acute illness, and acute stress can all distort fasting insulin readings.

Several medications can raise or lower fasting insulin. Steroids, oral contraceptives (some formulations), some psychiatric medications, and beta-blockers can raise insulin levels. Metformin and other insulin-sensitising medications can lower them. Patients are usually asked to mention all current medications and supplements before the test.

Pregnancy substantially changes baseline insulin levels — pregnancy reference ranges are different and obstetric guidance applies. Acute infections, sleep deprivation, and irregular meal patterns in the days before the test can also shift the value.

When to talk to your doctor

  • Your fasting insulin is high while your fasting glucose is still in the normal range — this is a common pattern of early insulin resistance and is worth discussing.
  • You have PCOS, fatty liver, central obesity, or acanthosis nigricans — fasting insulin findings should be interpreted in that wider context.
  • Your HOMA-IR is calculated and falls above the lab's cut-off — it does not by itself diagnose diabetes, but it does signal metabolic risk.
  • Your fasting insulin is unexpectedly low alongside a high fasting glucose — this combination needs medical interpretation and is not necessarily a typical type-2 diabetes pattern.
  • You are starting, stopping, or changing a medication known to affect insulin levels — discuss whether the timing of the test should change.

Related tests

Sources

  • RSSDI Clinical Practice Recommendations — Research Society for the Study of Diabetes in India
  • Indian Consensus on PCOS (FOGSI) — Federation of Obstetric and Gynaecological Societies of India
  • ICMR Guidelines for Management of Type 2 Diabetes — Indian Council of Medical Research
  • HOMA-IR methodology — original publication — Matthews DR et al., Diabetologia (1985)
  • Insulin Assay Standardisation — International Federation of Clinical Chemistry (IFCC)

See our medical disclaimer for what this content is and is not.

Frequently asked questions

Not by itself. Fasting glucose and HbA1c are the primary tests used to diagnose diabetes. Fasting insulin is more useful for assessing insulin resistance — the underlying mechanism behind most type-2 diabetes — rather than diabetes itself. It is often ordered alongside fasting glucose to calculate HOMA-IR.

Insulin testing is not as standardised as glucose testing — different labs use different assays and instruments, and the international 'common reference standard' for insulin is still evolving. This is why two readings from different labs cannot be directly compared. Always interpret the value against the range printed on the same report.

HOMA-IR is a calculated score that combines fasting insulin and fasting glucose into a single number meant to estimate insulin resistance. The formula is (fasting insulin in µIU/mL × fasting glucose in mg/dL) ÷ 405. A higher number suggests the pancreas is releasing more insulin to keep fasting sugar in range. Different clinical groups use slightly different cut-offs.

Insulin resistance is very common in PCOS, often even when body weight is normal. Knowing the fasting insulin level (and HOMA-IR) helps the doctor decide whether interventions aimed at improving insulin sensitivity — lifestyle changes, certain medications — are likely to help with PCOS symptoms.

Often, yes. Loss of central (abdominal) weight, increased physical activity (particularly resistance training and brisk walking), better sleep, and reduced refined-carbohydrate intake all tend to improve insulin sensitivity over weeks to months. Your doctor may also recommend specific medications in some situations. Aim for changes the doctor confirms are appropriate for your overall picture.

Track your Fasting Insulin over the years.

Get Medfolio and see how your Fasting Insulin is moving — visit by visit, lab by lab.

Coming soon to Google Play. Coming soon on the App Store.

See how diabetes tracking works — no app needed to read about it.